# FVCBankcorp, Inc.: financial statements, quarterly

FVCB · Nasdaq · CIK 1675644 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fvcb.md) · [Financials](/companies/fvcb/financials.md) · [Filings](/companies/fvcb/filings.md) · [Insiders](/companies/fvcb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fvcb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.4](/filings/0001675644-24-000192.md) | [0.4 d](/filings/0001675644-25-000035.md) | [0.4](/filings/0001675644-25-000090.md) | [0.4](/filings/0001675644-24-000150.md) | [0.4](/filings/0001675644-25-000146.md) | [0.4 d](/filings/0001675644-26-000023.md) | [0.4](/filings/0001675644-26-000059.md) | [0.4](/filings/0001675644-26-000081.md) | [0.4](/filings/0001675644-25-000146.md) | [0.6 d](/filings/0001675644-26-000023.md) | [0.5](/filings/0001675644-26-000059.md) | [0.5](/filings/0001675644-26-000081.md) |
| Interest expense | $m | [14.1](/filings/0001675644-23-000122.md) | [14.0 d](/filings/0001675644-24-000036.md) | [14.0](/filings/0001675644-24-000077.md) | [14.3](/filings/0001675644-24-000150.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.2](/filings/0001675644-24-000192.md) | [0.4](/filings/0001675644-25-000035.md) | [3.2](/filings/0001675644-25-000090.md) | [1.2](/filings/0001675644-25-000126.md) | [1.4](/filings/0001675644-25-000146.md) | [1.5 d](/filings/0001675644-26-000023.md) | [1.2](/filings/0001675644-26-000059.md) | [1.6](/filings/0001675644-26-000081.md) | [1.6](/filings/0001675644-25-000146.md) | [1.8 d](/filings/0001675644-26-000023.md) | [1.9](/filings/0001675644-26-000059.md) | [2.2](/filings/0001675644-26-000081.md) |
| Net income | $m | [4.0](/filings/0001675644-24-000192.md) | [(5.1) d](/filings/0001675644-25-000035.md) | [1.3](/filings/0001675644-25-000090.md) | [4.2](/filings/0001675644-25-000126.md) | [4.7](/filings/0001675644-25-000146.md) | [4.9 d](/filings/0001675644-26-000023.md) | [5.2](/filings/0001675644-26-000059.md) | [5.7](/filings/0001675644-26-000081.md) | [5.6](/filings/0001675644-25-000146.md) | [5.6 d](/filings/0001675644-26-000023.md) | [6.4](/filings/0001675644-26-000059.md) | [8.2](/filings/0001675644-26-000081.md) |
| Diluted EPS | $ per share | [0.22](/filings/0001675644-24-000192.md) | not reported | [0.07](/filings/0001675644-25-000090.md) | [0.23](/filings/0001675644-25-000126.md) | [0.25](/filings/0001675644-25-000146.md) | not reported | [0.28](/filings/0001675644-26-000059.md) | [0.31](/filings/0001675644-26-000081.md) | [0.31](/filings/0001675644-25-000146.md) | not reported | [0.35](/filings/0001675644-26-000059.md) | [0.45](/filings/0001675644-26-000081.md) |
| Basic EPS | $ per share | [0.23](/filings/0001675644-24-000192.md) | not reported | [0.08](/filings/0001675644-25-000090.md) | [0.23](/filings/0001675644-25-000126.md) | [0.26](/filings/0001675644-25-000146.md) | not reported | [0.28](/filings/0001675644-26-000059.md) | [0.31](/filings/0001675644-26-000081.md) | [0.31](/filings/0001675644-25-000146.md) | not reported | [0.36](/filings/0001675644-26-000059.md) | [0.46](/filings/0001675644-26-000081.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [2,305](/filings/0001675644-23-000122.md) | [2,191](/filings/0001675644-25-000035.md) | [2,183](/filings/0001675644-24-000077.md) | [2,299](/filings/0001675644-24-000150.md) | [2,293](/filings/0001675644-24-000192.md) | [2,199](/filings/0001675644-26-000023.md) | [2,241](/filings/0001675644-25-000090.md) | [2,237](/filings/0001675644-25-000126.md) | [2,319](/filings/0001675644-25-000146.md) | [2,292](/filings/0001675644-26-000081.md) | [2,335](/filings/0001675644-26-000059.md) | [2,367](/filings/0001675644-26-000081.md) |
| Total liabilities | $m | [2,094](/filings/0001675644-23-000122.md) | [1,973](/filings/0001675644-25-000035.md) | [1,962](/filings/0001675644-24-000077.md) | [2,073](/filings/0001675644-24-000150.md) | [2,062](/filings/0001675644-24-000192.md) | [1,964](/filings/0001675644-26-000023.md) | [1,998](/filings/0001675644-25-000090.md) | [1,994](/filings/0001675644-25-000126.md) | [2,069](/filings/0001675644-25-000146.md) | [2,039](/filings/0001675644-26-000081.md) | [2,075](/filings/0001675644-26-000059.md) | [2,101](/filings/0001675644-26-000081.md) |
| Shareholders' equity | $m | [211](/filings/0001675644-24-000192.md) | [217](/filings/0001675644-26-000023.md) | [221](/filings/0001675644-25-000126.md) | [226](/filings/0001675644-25-000146.md) | [231](/filings/0001675644-25-000146.md) | [235](/filings/0001675644-26-000081.md) | [242](/filings/0001675644-26-000081.md) | [243](/filings/0001675644-26-000081.md) | [250](/filings/0001675644-25-000146.md) | [254](/filings/0001675644-26-000081.md) | [260](/filings/0001675644-26-000081.md) | [267](/filings/0001675644-26-000081.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [6,252 d](/filings/0001675644-24-000192.md) | [4,529 d](/filings/0001675644-25-000035.md) | [7,152](/filings/0001675644-25-000090.md) | [1,552 d](/filings/0001675644-25-000126.md) | [4,680 d](/filings/0001675644-25-000146.md) | [4,848 d](/filings/0001675644-26-000023.md) | [5,416](/filings/0001675644-26-000059.md) | [3,288 d](/filings/0001675644-26-000081.md) | [7,564 d](/filings/0001675644-25-000146.md) | [7,591 d](/filings/0001675644-26-000023.md) | [7,627](/filings/0001675644-26-000059.md) | [8,931 d](/filings/0001675644-26-000081.md) |
| Capital expenditure | $k | [43.0 d](/filings/0001675644-24-000192.md) | [79.0 d](/filings/0001675644-25-000035.md) | [14.0](/filings/0001675644-25-000090.md) | [53.0 d](/filings/0001675644-25-000126.md) | [58.0 d](/filings/0001675644-25-000146.md) | [16.0 d](/filings/0001675644-26-000023.md) | [16.0](/filings/0001675644-26-000059.md) | [13.0 d](/filings/0001675644-26-000081.md) | [1.0 d](/filings/0001675644-25-000146.md) | [17.0 d](/filings/0001675644-26-000023.md) | [12.0](/filings/0001675644-26-000059.md) | [14.0 d](/filings/0001675644-26-000081.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001675644-26-000023.md) | [0.0](/filings/0001675644-26-000059.md) | [0.0 d](/filings/0001675644-26-000081.md) | [1,084 d](/filings/0001675644-25-000146.md) | [1,083 d](/filings/0001675644-26-000023.md) | [1,075](/filings/0001675644-26-000059.md) | [1,270](/filings/0001675644-26-000081.md) |
| Share repurchases | $k | [0.0 d](/filings/0001675644-24-000192.md) | [12.0 d](/filings/0001675644-25-000035.md) | [0.0](/filings/0001675644-24-000077.md) | [0.0 d](/filings/0001675644-25-000126.md) | [0.0 d](/filings/0001675644-25-000146.md) | [0.0 d](/filings/0001675644-26-000023.md) | not reported | not reported | [0.0 d](/filings/0001675644-25-000146.md) | [2,042 d](/filings/0001675644-26-000023.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [18.5](/filings/0001675644-23-000122.md) | [18.3](/filings/0001675644-24-000077.md) | [18.1](/filings/0001675644-24-000150.md) | [18.3](/filings/0001675644-24-000192.md) | [0.0](/filings/0001675644-25-000090.md) | [18.3](/filings/0001675644-25-000126.md) | [0.0](/filings/0001675644-25-000146.md) | [18.5](/filings/0001675644-26-000059.md) | [0.0](/filings/0001675644-26-000081.md) | [0.0](/filings/0001675644-25-000146.md) | [18.1](/filings/0001675644-26-000059.md) | [18.2](/filings/0001675644-26-000081.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,034,205 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001675644-26-000081.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.